B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GPX4

MOLECULAR TARGET

glutathione peroxidase 4

NCBI Gene: 287925 compounds

GPX4 (glutathione peroxidase 4) is targeted by 25 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GPX4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1amlexanox1.102
2cbd0.691
3obeticholic acid [Supplementary Concept]0.691
4Mepentol [Supplementary Concept]0.691
5Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
6Vitamin0.691
7Camptothecin0.691
8candesartan cilexetil [Supplementary Concept]0.691
9cannabidiol0.691
10Cefotetan0.691
11Cephaloglycin0.691
12Cisplatin0.691
13Dipyrone0.691
14Dithiazanine 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium.0.691
15Ethoxyquin Antioxidant; also0.691
16gamma-Linolenic Acid0.691
17Gestrinone0.691
18Hexachlorophene0.691
19Lypressin0.691
20Methyldopa0.691
21Masoprocol0.691
22Ornipressin0.691
23stx640.691
24Trenbolone Acetate0.691
25Triiodothyronine0.691

About GPX4 as a Drug Target

GPX4 (glutathione peroxidase 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 25 compounds with documented GPX4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GPX4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.